According to the Early Treatment Diabetic Retinopathy Study (ETDRS) classification, which of the following defines the transition from non-proliferative to proliferative diabetic retinopathy?

Explanation

## ETDRS Classification: NPDR to PDR Transition **Key Point:** The defining feature of proliferative diabetic retinopathy (PDR) is the appearance of **neovascularization** — new vessels on the disc (NVD) or elsewhere (NVE) — which marks the transition from non-proliferative to proliferative disease. ### ETDRS Severity Levels | Level | Features | Neovascularization | |-------|----------|--------------------| | Mild NPDR | ≥1 microaneurysm, no more | Absent | | Moderate NPDR | Microaneurysms + hard exudates, cotton-wool spots, venous abnormalities | Absent | | Severe NPDR | Venous beading in ≥2 quadrants, IRMA, extensive retinal hemorrhages | Absent | | Very Severe NPDR | 2+ features of severe NPDR | Absent | | PDR | Any neovascularization (NVD or NVE) | **Present** | **High-Yield:** - Neovascularization is the pathologic hallmark of PDR, driven by retinal ischemia and VEGF upregulation - NVD (new vessels on disc) is more common and carries higher risk of vitreous hemorrhage - NVE (new vessels elsewhere) is less common but still defines PDR - The presence of ANY neovascularization = PDR, regardless of other findings **Mnemonic: IRMA-VB-NV** — Intraretinal Microvascular Abnormalities, Venous Beading, and Neovascularization are the three cardinal signs of severe NPDR and PDR; only NV defines the transition to PDR. **Clinical Pearl:** A patient with severe NPDR (venous beading, IRMA, extensive hemorrhages) without neovascularization is still non-proliferative and may be managed medically; the moment new vessels appear, PDR is present and urgent intervention (laser or anti-VEGF) is indicated. [cite:Early Treatment Diabetic Retinopathy Study (ETDRS) Report 10]